Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial

Jacob Elkins, Mitchell S.V. Elkind, Lahar Mehta et al.|The Lancet Neurology|2017

Cited by 213